Search results
The Clinician’s Guide offers concise recommendations regarding prevention, risk assessment, diagnosis, and treatment of osteoporosis in postmenopausal women and men aged 50 years and older. It includes indications for bone densitometry as well as fracture risk thresholds for pharmacologic intervention.
Consider, particularly in older people, drug treatment in those with a prior and/or recent fragility fracture. When selecting drug treatments to prevent fractures in postmenopausal women, and men age ≥50:
The older senior is at high risk for osteoporosis. It is important for healthcare providers to be fully aware of the potential risks and benefits of diagnosing and treating osteoporosis in the older senior population. Data indicate that bone mineral density testing is under-utilized and drug therapy is often not initiated when indicated in this ...
The process of bone remodeling that maintains a healthy skeleton may be considered a preventive maintenance program, continually removing older bone and replacing it with new bone. Bone loss occurs when this balance is altered, resulting in greater bone removal than replacement.
Scope of this guideline. Section 2. Introduction to osteoporosis and fragility fractures. Section 3. Fracture risk assessment and case finding. Section 4. Intervention thresholds and strategy. Section 5. Non-pharmacological management of osteoporosis.
NOGG provides a clinical guideline that reviews the assessment and diagnosis of osteoporosis, the therapeutic interventions available and the approaches for the prevention of fragility fractures, in postmenopausal women, and in men aged 50 years or older.
12 mar 2022 · Summary. The goal of osteoporosis management is to prevent fractures. Several pharmacological agents are available to lower fracture risk, either by reducing bone resorption or by stimulating bone formation.
